Anesthesia in patients with infectious disease caused by multi-drug resistant bacteria

Sharon Einav1, Yonit Wiener-Well

  • 1aThe Surgical Intensive Care Unit bThe Infectious Disease Unit, Shaare Zedek Medical Center and the Hebrew University, Faculty of Medicine, Jerusalem, Israel.

Abstract

Insights

Anesthesiologists can reduce multi-drug resistant organism (MDRO) transmission in operating rooms. Proper training and sterile techniques are crucial for anesthesia providers managing patients at risk of MDRO infection.

Area of Science:

  • Infection Control
  • Anesthesiology
  • Microbiology

Background:

  • Multi-drug resistant organisms (MDROs) are prevalent in healthcare settings, with up to 50% of certain bacterial strains exhibiting resistance.
  • Anesthesiologists play a role in managing patients carrying or at risk of carrying MDROs, potentially impacting transmission within the Operating Room (OR).

Purpose of the Study:

  • To highlight the critical role of anesthesiologists in preventing MDRO transmission within the OR.
  • To emphasize the need for including anesthesia providers in discussions and strategies for managing patients with or at risk of MDROs.

Main Methods:

  • Review of current literature and outbreak investigations implicating anesthesiologists and their environment in MDRO transmission.
  • Analysis of contamination sources and procedural gaps in anesthesia practice related to MDROs.
  • Evaluation of infection control interventions and training needs for anesthesia staff.

Main Results:

  • Anesthesia providers, equipment, and the OR environment (ventilation circuits, non-disposable equipment, workstations) have been identified as potential sources of MDRO transmission.
  • Inadequate decontamination procedures and lack of training in sterile drug management contribute to MDRO spread.
  • Current practices may not sufficiently address the risks associated with MDRO carriers in the perioperative setting.

Conclusions:

  • Anesthesia providers must be integral to developing and implementing infection control strategies for MDRO carriers.
  • Formal training in sterile drug handling and identification of at-risk patients is essential for anesthesia staff.
  • Enhanced environmental cleaning methods (e.g., UV irradiation) and consideration of adjuvant therapies may further reduce MDRO transmission.

Related Concept Videos

General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
906
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
975
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.3K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.7K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K